Related Experiment Video
Updated: Jan 23, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Myocardial transit time mapping by CMR: A novel potential parameter of microcirculatory dysfunction in hypertrophic
Junlin Yang1, Yong Cheng1, Jinxiu Yang1
1Department of Radiology, The First Affiliated Hospital of Anhui Medical University, No.218 Jixi Road, Hefei, Anhui 230022, China.
Insights
Myocardial transit time (MyoTT) measured by cardiovascular magnetic resonance (CMR) is elevated in hypertrophic cardiomyopathy (HCM) patients, especially those with atrial fibrillation (AF). This parameter may indicate coronary microvascular dysfunction (CMD) in HCM.
Area of Science:
- Cardiology
- Medical Imaging
- Biophysics
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart condition often associated with coronary microvascular dysfunction (CMD).
- Atrial fibrillation (AF) is a common complication in HCM patients, potentially worsening prognosis.
- Current methods for assessing CMD in HCM have limitations.
Purpose of the Study:
- To investigate myocardial transit time (MyoTT) using cardiovascular magnetic resonance (CMR) as a potential biomarker for CMD in HCM.
- To evaluate the association of MyoTT with HCM and AF status.
- To compare the diagnostic performance of MyoTT with other CMR-derived parameters.
Main Methods:
- A cohort of 50 HCM patients and 50 healthy controls underwent CMR scans.
- Parameters assessed included cardiac function, native T1, extracellular volume (ECV), myocardial strain, and MyoTT.
- Logistic regression and receiver operating characteristic (ROC) analyses were used to evaluate associations and discriminative performance.
Main Results:
- HCM patients showed significantly altered cardiac function, increased native T1, ECV, and MyoTT compared to controls.
- MyoTT, native T1, ECV, and LV-GLS were significantly associated with HCM status.
- In HCM patients, higher native T1 and MyoTT values were observed in those with AF.
- MyoTT demonstrated good discriminative performance for HCM (AUC=0.848) and for AF within HCM (AUC=0.740).
Conclusions:
- MyoTT is elevated in HCM patients and is associated with the presence of AF.
- MyoTT may serve as a valuable non-invasive imaging marker for CMD in HCM, particularly in the context of AF.
- Further research is warranted to explore the clinical implications of MyoTT in HCM management.
Purpose:
This study aimed to explore myocardial transit time (MyoTT) by cardiovascular magnetic resonance (CMR) as a potential parameter of coronary microvascular dysfunction (CMD) in hypertrophic cardiomyopathy (HCM) with and without atrial fibrillation (AF).
Materials And Methods:
This study enrolled 50 patients with HCM and 50 healthy control subjects to assess cardiac function, native T1, extracellular volume (ECV), myocardial strain, and MyoTT. Factors associated with HCM status were estimated by logistic regression analyses, adjusting for potential confounders. Meanwhile, we evaluated the discriminative performance of the aforementioned parameters for HCM (vs control) and for AF status among HCM patients.
Results:
In the HCM and control groups, the HCM group exhibited significant reductions in LV-GLS, RV-EDVI, and RV-ESVI (all P < 0.05) and significant increases in LVMI, LVGPWT, native T1 values, ECV values, absolute MyoTT values and presence of LGE (all P < 0.05). Logistic regression analysis revealed HCM was significantly associated with MyoTT, native T1, ECV and LV-GLS. In HCM with and without AF, the HCM with AF group showed nominally higher native T1 values and absolute MyoTT values before correction. Logistic regression analysis revealed HCM with AF was significantly associated with MyoTT and native T1. The AUCs for ECV, MyoTT, LV-GLS, and native T1 were 0.828, 0.848, 0.708, and 0.862, respectively (P < 0.05). The AUCs for discriminating HCM with AF from HCM without AF for MyoTT and native T1 were 0.740 and 0.681, respectively (P < 0.05).
Conclusion:
MyoTT levels are elevated in patients with HCM, particularly when AF is present. This suggests that MyoTT may reflect CMD-related alterations in HCM, especially in those with AF.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Phase Transitions

